Upcoming Webinar: ISN-KDIGO Webinar on Coronary Artery & Valvular Diseases
ISN Academy. Sarnak M. Nov 22, 2018; 234651
Topic: Chronic kidney disease
Login now to access Regular content available to all registered users.

You may also access ISN content "anytime, anywhere" with the FREE ISN Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Please register for ISN-KDIGO webinar: Coronary Artery & Valvular Diseases on Dec 14, 2018 3:00 PM CET by clicking the "Register Now' button. Abstract CKD is a major risk factor for coronary artery disease (CAD) and valvular disease. In addition to having a high prevalence of traditional CVD risk factors such as diabetes and hypertension, persons with CKD are also exposed to other non-traditional, uremia-related cardiovascular disease risk factors. Management of CAD and valvular disease is complicated in CKD patients given their likelihood of comorbid conditions and potential for side effects. A better understanding of the epidemiology, pathophysiology, diagnosis, and treatment of CAD and valvular disease in CKD is therefore necessary Learning Objectives 1. To understand the epidemiology, risk factors and use of risk equations to estimate CAD and valvular disease in CKD 2. To describe the pathophysiology and diagnosis of CAD and valvular disease in CKD 3. To appreciate treatment options for CAD and valvular disease in CKD 4. To prioritize research questions with regards to CAD and valvular disease in CKD Speaker Biography Dr. Sarnak is Chief of the Division of Nephrology and Professor of Medicine at Tufts University School of Medicine. His research focuses on traditional and non-traditional CVD risk factors in CKD, cognitive function and CKD and novel biomarkers of CKD. His research is funded by the NIDDK and the NIA and he is a previous Garabed Eknoyan Awardee of the NKF. He was on the Steering Committee for both the KDIGO Controversies Conference on Heart Failure in CKD and Blood Pressure (BP) in CKD and is currently a Steering Committee Member of the KDIGO BP Guideline Update that will take place in 2019. After registering, you will receive a confirmation email containing information about joining the webinar.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings